BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEBBoehringer, Insilico Appear to Break Through Against IPF. Clinical trial results shared by Boehringer Ingelheim and Insilico Medicine showed improvement in idiopathic pulmonary fibrosis, an intractable lung disease for which current treatment options fail to stop progression, but the data were limited, leaving experts wanting. September 24, 2024.
News - BioSpace
WEBAlina Zahid. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news from BioSpace.
HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are popular because they are fast-growing and robust. Additionally, due to the efficiency of HEK 293 cells, they generate exogenous proteins used in biomedical and pharmaceutical research.
Biomedical Engineering Career Options: Best Opportunities and …
WEBJun 18, 2021 · Experience. Experience in the field is highly advised. For those who are just starting, becoming a research assistant at the college level is extremely important and could do a lot to beef up your resume. 2. Improving Resume. Showing a solid experience/career summary in biomedical engineering career options is a plus.
AstraZeneca’s Imfinzi Scores Lung Cancer Wins With FDA’s
WEBAug 16, 2024 · AstraZeneca touted two lung cancer victories on Thursday with its blockbuster PD-1 inhibitor Imfinzi (durvalumab) securing the FDA’s nod for a perioperative label expansion in non-small cell lung cancer, as well as the regulator’s Priority Review and Breakthrough Therapy designations for small cell lung cancer.. The perioperative approval came as a bit of a surprise.
House Lawmakers Raise Alarm About US Biopharma Companies
WEBAug 21, 2024 · With the BIOSECURE Act poised for a vote in the House of Representatives, a congressional committee is urging the FDA to look into U.S. biopharmaceutical companies that have allegedly worked with the Chinese military to conduct clinical trials in Xinjiang.. In a letter to FDA Commissioner Robert Califf, the House Select Committee on the CCP flagged the “alarming practice” of some U.S ...
Scientist I, Scientist II and Senior Scientist Roles, Explained
WEBOct 28, 2020 · Scientist II. These roles can encompass similar responsibilities of a Scientist I position, but they generally involve more complex projects. Scientist II candidates usually have at least 2-3 years of practical experience in an area, as well as an understanding of knowledge and theory within the field. While some Scientist II positions only ...
Biotech Bay - BioSpace
WEBSep 24, 2024 · Biotech Bay. The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and start-ups alike and is a center for cutting-edge science and medicine. Major research universities in the region, including Stanford ...
Wet Lab vs Dry Lab: Challenges, Benefits and Skills Required
WEBJan 25, 2023 · In a wet lab, testing and analyses are performed using physical samples, chemicals and liquids. Biological samples, drugs and fluids are all tested in a wet lab. In other words, “wet” materials are tested. In a dry lab, testing and analyses is performed using data, coding and computer systems. Modeling and analysis normally take place in a ...
BioMarin Brings on Roche, Amgen Alums in Executive Restructuring
WEBAug 22, 2024 · BioMarin rolled out an executive reorganization on Wednesday, appointing veterans of pharma powerhouses Amgen and Roche to its C-suite, as the biotech narrows its sales effort for the hemophilia A gene therapy Roctavian to focus on the U.S., German and Italian markets.. Greg Friberg, who was formerly the vice president of global medical affairs for rare diseases at Amgen, will serve as ...